Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
Top Cited Papers
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 119 (6), 1637-1648
- https://doi.org/10.1053/gast.2000.20189
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisoloneGastroenterology, 1996
- Cytokine-induced neutrophil chemoattractant release from hepatocytes is modulated by Kupffer cellsHepatology, 1996
- Cytokine levels in acute alcoholic hepatitis: a sequential studyDrug and Alcohol Dependence, 1995
- Pentoxifylline for Intermittent ClaudicationAngiology, 1994
- Increased plasma interleukin-8 concentrations in alcoholic hepatitisHepatology, 1993
- A Randomized Trial of Prednisolone in Patients with Severe Alcoholic HepatitisNew England Journal of Medicine, 1992
- Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patientsHepatology, 1991
- Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.The Journal of Experimental Medicine, 1990
- Plasma Tumor Necrosis Factor α Predicts Decreased Long‐Term Survival in Severe Alcoholic HepatitisAlcohol: Clinical and Experimental Research, 1990
- PentoxifyllineDrugs, 1987